Dexrazoxane Intravenous and Insulin Degludec (U-100) Vials
Determining the interaction of Dexrazoxane Intravenous and Insulin Degludec (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Insulin Degludec (U-200) Prefilled Pens
- Dexrazoxane Intravenous-Insulin degludec and liraglutide
- Dexrazoxane Intravenous-Insulin degludec and liraglutide Subcutaneous
- Dexrazoxane Intravenous-Insulin degludec Subcutaneous
- Dexrazoxane Intravenous-Insulin detemir
- Dexrazoxane Intravenous-Insulin Detemir (Cartridges and Prefilled Syringes)
- Insulin Degludec (U-100) Vials-Dextenza Insert
- Insulin Degludec (U-100) Vials-Dextenza intraocular
- Insulin Degludec (U-100) Vials-Dextran 40
- Insulin Degludec (U-100) Vials-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin Degludec (U-100) Vials-Dextran 75
- Insulin Degludec (U-100) Vials-Dextran high molecular weight